Your browser doesn't support javascript.
loading
Is there a role for chemotherapy and radiation in the treatment of patients with low-grade myofibroblastic sarcoma?
Xu, Y; Xu, G; Wang, X; Mao, M; Wu, H; Baklaushev, V P; Chekhonin, V P; Peltzer, K; Wang, G; Zhang, C.
Afiliação
  • Xu Y; Department of Bone and Soft Tissue Tumors, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China.
  • Xu G; Department of Bone and Soft Tissue Tumors, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China.
  • Wang X; Department of Orthopaedics, Tianjin Hospital, Tianjin, China.
  • Mao M; Department of Epidemiology and Biostatistics, First Affiliated Hospital, Army Medical University, Chongqing, China.
  • Wu H; Department of Pathology and Southwest Cancer Center, First Affiliated Hospital, Army Medical University, Chongqing, China.
  • Baklaushev VP; Department of Bone and Soft Tissue Tumors, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China.
  • Chekhonin VP; Federal Research and Clinical Center of Specialized Medical Care and Medical Technologies, Federal Biomedical Agency of the Russian Federation, Moscow, Russian Federation.
  • Peltzer K; Department of Basic and Applied Neurobiology, Federal Medical Research Center for Psychiatry and Narcology, Moscow, Russian Federation.
  • Wang G; Department of Research and Innovation, University of Limpopo, Turfloop, South Africa.
  • Zhang C; Department of Bone and Soft Tissue Tumors, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China. wangguowen@tmu.edu.cn.
Clin Transl Oncol ; 23(2): 344-352, 2021 Feb.
Article em En | MEDLINE | ID: mdl-32607812
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Raras / Fibrossarcoma Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Transl Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Itália
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Raras / Fibrossarcoma Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Transl Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Itália